Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chengxin Li, Jiejiu Lu, Siru Zhou, Yinyi Wei, Chunle Lv, Taotao Liu, Yun Wu, Dongni Wu, Jianying Qi & Rongda Cai. (2021) Influential Factors and Efficacy Analysis of Tacrolimus Concentration After Allogeneic Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major. Pharmacogenomics and Personalized Medicine 14, pages 1221-1237.
Read now
Read now
Lizhi Chen, Yunyun Yang, Xuebin Wang, Chenyu Wang, Weiwei Lin, Zheng Jiao & Zhuo Wang. (2021) Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis. Pharmacogenomics and Personalized Medicine 14, pages 1093-1106.
Read now
Read now
Ahmed Shaker Ali, Abdullah Saddah Almalki & Basma Tarek Alharthy. (2020) Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model. Journal of Experimental Pharmacology 12, pages 397-407.
Read now
Read now
G. Moroni & C. Ponticelli. (2017) Synthetic pharmacotherapy for lupus nephritis. Expert Opinion on Pharmacotherapy 18:2, pages 175-186.
Read now
Read now
Articles from other publishers (102)
Adrien Paschier, Alexandre Destere, Caroline Monchaud, Marc Labriffe, Pierre Marquet & Jean‐Baptiste Woillard. (2023) Tacrolimus population pharmacokinetics in adult heart transplant patients. British Journal of Clinical Pharmacology 89:12, pages 3584-3595.
Crossref
Crossref
Amani Abderahmene, Marith I. FranckeLouise M. AndrewsDennis A. HesselinkDorra AmorWissal Sahtout, Marwa AjmiHayfa MastouriAli BouslamaDorsaf Zellama, Asma OmezzineBrenda C. M. De Winter. (2023) A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus for Tunisian Adults after Renal Transplantation. Therapeutic Drug Monitoring.
Crossref
Crossref
Ripudaman S Munjal, Jagdish Sharma, Srinija Polishetti, Pushkar Sai Valleru, Himanshi Banker, Ramansh Bandhu Gupta, FNU Anamika & Rohit Jain. (2023) Beyond Immunosuppression: The Intricate Relationship Between Tacrolimus and Microangiopathy. Cureus.
Crossref
Crossref
Kamilė Stankevičiūtė, Jean-Baptiste Woillard, Richard W. Peck, Pierre Marquet & Mihaela van der Schaar. (2023) Bridging the Worlds of Pharmacometrics and Machine Learning. Clinical Pharmacokinetics 62:11, pages 1551-1565.
Crossref
Crossref
Limin Cai, Meng Ke, Han Wang, Wanhong Wu, Rongfang Lin, Pinfang Huang & Cuihong Lin. (2023) Physiologically based pharmacokinetic model combined with reverse dose method to study the nephrotoxic tolerance dose of tacrolimus. Archives of Toxicology 97:10, pages 2659-2673.
Crossref
Crossref
Osnat ShtraichmanMDMD & Mordechai R. KramerMDMD. 2023. Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease. Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease
1240
1267
.
Maaike R. Schagen, Asiye Nur Ulu, Marith I. Francke, Jacqueline van de Wetering, Marleen C. van Buren, Sam Schoenmakers, Maja Matic, Ron H. N. van Schaik, Dennis A. Hesselink & Brenda C. M. de Winter. (2023) Modelling changes in the pharmacokinetics of tacrolimus during pregnancy after kidney transplantation: A retrospective cohort study. British Journal of Clinical Pharmacology.
Crossref
Crossref
Bradley Miyagawa, Danielle Lazear, David K. Hooper, Alexander A. Vinks & Tomoyuki Mizuno. (2023) Model-Informed Estimation of Acutely Decreased Tacrolimus Clearance and Subsequent Dose Individualization in a Pediatric Renal Transplant Patient With Posterior Reversible Encephalopathy Syndrome. Therapeutic Drug Monitoring 45:3, pages 376-382.
Crossref
Crossref
Koos de Wit, Ulrich Beuers, Anna Mukha, Edwin C. A. Stigter, M. Can Gulersonmez, Jose M. Ramos Pittol, Sabine Middendorp, R. Bart Takkenberg & Saskia W. C. van Mil. (2022)
Rifaximin stimulates nitrogen detoxification by
PXR
‐independent mechanisms in human small intestinal organoids
. Liver International 43:3, pages 649-659.
Crossref
Crossref
Meiling Zuo, Yue Shang, Ye Guo, Yuxuan Sun, Gaoqi Xu, Jingtao Chen & Liqin Zhu. (2022) Population Pharmacokinetics of Tacrolimus in Pediatric Patients With Umbilical Cord Blood Transplant. The Journal of Clinical Pharmacology 63:3, pages 298-306.
Crossref
Crossref
Kathleen M. Tornatore, Kris Attwood, Daniel Brazeau, Jason Sprowl, Shirley Chang, Aijaz Gundroo, Hans Minderman & Rocco C. Venuto. (2022) Comparison of P‐glycoprotein function in peripheral blood mononuclear cells ex vivo in stable Black and White male and female kidney transplant recipients. Clinical and Translational Science 16:2, pages 184-192.
Crossref
Crossref
Kaikai Lv, Yangyang Wu, Wenhui Lai, Xiaowei Hao, Xinze Xia, Shuai Huang, Zhenjun Luo, Chao Lv, Yuan Qing & Tao Song. (2023) Simpson's paradox and the impact of donor-recipient race-matching on outcomes post living or deceased donor kidney transplantation in the United States. Frontiers in Surgery 9.
Crossref
Crossref
Jean-Baptiste Woillard, Caroline Monchaud, Franck Saint-Marcoux, Marc Labriffe & Pierre Marquet. (2022) Can the Area Under the Curve/Trough Level Ratio Be Used to Optimize Tacrolimus Individual Dose Adjustment?. Transplantation 107:1, pages e27-e35.
Crossref
Crossref
Onyedika J. Ilonze, Denise C. VidotKhadijah Breathett, Marlene Camacho-RiveraSubha V. RamanJon A. KobashigawaLarry A. Allen. (2022) Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes. Circulation: Heart Failure 15:12.
Crossref
Crossref
Brian I. Shaw, Hui‐Jie Lee, Robert Ettenger, Paul Grimm, Elaine F. Reed, Minnie Sarwal, Linda Stempora, Barry Warshaw, Congwen Zhao, Olivia M. Martinez, Nancie J. MacIver, Allan D. Kirk & Eileen T. Chambers. (2022) Malnutrition and immune cell subsets in children undergoing kidney transplantation. Pediatric Transplantation 26:8.
Crossref
Crossref
Mary Thoma, Kimberly Langer, Patricia McLean & David Dingli. (2022) The Impact of Pharmacogenomic CYP3A5 Variants on Calcineurin Inhibitor Metabolism and SLCO1B1 Variants on Methotrexate in Adult Allogeneic BMT Patients. Transplantation Reports 7:4, pages 100115.
Crossref
Crossref
Xiao-Jun Cai, Rui-Dong Li, Jian-Hua Li, Yi-Feng Tao, Quan-Bao Zhang, Cong-Huan Shen, Xiao-Fei Zhang, Zheng-Xin Wang & Zheng Jiao. (2022) Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models. Frontiers in Pharmacology 13.
Crossref
Crossref
Siyao Yang, Haixia Jiang, Chengcheng Li, Huijie Lu, Chuanjiang Li, Demei Ye, Huana Qi, Wenbin Xu, Xiaojie Bao, Nicola Maseko, Siqi Zhang, Ruifan Shao & Liang Li. (2022) Genomewide association study identifies a novel variant associated with tacrolimus trough concentration in Chinese renal transplant recipients. Clinical and Translational Science 15:11, pages 2640-2651.
Crossref
Crossref
Boyang Xie, Chenyu Huang & Fangqing Gu. (2022) Optimizing Dosing Regimens of Tacrolimus in Lung Transplant Recipients. Optimizing Dosing Regimens of Tacrolimus in Lung Transplant Recipients.
Miłosz Miedziaszczyk, Aleksander Bajon, Ewelina Jakielska, Marta Primke, Jędrzej Sikora, Dagmara Skowrońska & Ilona Idasiak-Piechocka. (2022) Controversial Interactions of Tacrolimus with Dietary Supplements, Herbs and Food. Pharmaceutics 14:10, pages 2154.
Crossref
Crossref
Joris Guyon, Marine Novion, Virginie Fulda, Dominique Ducint, Mathieu Molimard, Lionel Couzi, Hannah Kaminski, Francesco Salvo & Stéphane Bouchet. (2022) A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case. Journal of the American Society for Mass Spectrometry 33:10, pages 1975-1981.
Crossref
Crossref
Jarrett Santorelli & Leslie Kobayashi. 2022. Surgical Critical Care and Emergency Surgery. Surgical Critical Care and Emergency Surgery
225
236
.
Abadil Samer, Fahad Almehmadi, Ahmed Krimly & Abdullah Alrajhi. (2022) Tacrolimus-Induced Diffuse Coronary Artery Spasm. Cureus.
Crossref
Crossref
Cristina Dopazo, Itxarone Bilbao, Sonia García, Concepción Gómez‐Gavara, Mireia Caralt, Isabel Campos‐Varela, Lluis Castells, Ernest Hidalgo, Francisco Moreso, Bruno Montoro & Ramón Charco. (2022) High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation. Clinical and Translational Science 15:6, pages 1544-1555.
Crossref
Crossref
Kaur Kulvinder Kochar, Allahbadia Gautam & Singh Mandeep. (2022) An update on the approaches of avoidance of propagation of chronic kidney disease resulting in reversal or possible need or avoidance of kidney transplantation - a systematic review. Journal of Clinical Nephrology 6:2, pages 040-057.
Crossref
Crossref
Ruben Faelens, Nicolas Luyckx, Dirk Kuypers, Thomas Bouillon & Pieter Annaert. (2022) Predicting model‐informed precision dosing: A test‐case in tacrolimus dose adaptation for kidney transplant recipients. CPT: Pharmacometrics & Systems Pharmacology 11:3, pages 348-361.
Crossref
Crossref
Lorena Santulario Verdú, Elena García-Romero & Carles Díez-López. (2022) Impacto clínico de la variabilidad en la concentración sanguínea de inhibidores de calcineurina en trasplante cardiaco: una espada de doble filo. Revista Española de Cardiología 75:2, pages 112-114.
Crossref
Crossref
Lorena Santulario Verdú, Elena García-Romero & Carles Díez-López. (2022) Clinical impact of variability in blood concentrations of calcineurin inhibitors in heart transplant: a double-edged sword. Revista Española de Cardiología (English Edition) 75:2, pages 112-114.
Crossref
Crossref
Kathleen M. Tornatore, Calvin J. Meaney, Kristopher Attwood, Daniel A. Brazeau, Gregory E. Wilding, Joseph D. Consiglio, Aijaz Gundroo, Shirley S. Chang, Vanessa Gray, Louise M. Cooper & Rocco C. Venuto. (2022) Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:2, pages 94-105.
Crossref
Crossref
Jorge Luis Sotelo & Melanie Bilbul. 2022. Transplant Psychiatry. Transplant Psychiatry
167
176
.
Giulio Di Mizio, Gianmarco Marcianò, Caterina Palleria, Lucia Muraca, Vincenzo Rania, Roberta Roberti, Giuseppe Spaziano, Amalia Piscopo, Valeria Ciconte, Nunzio Di Nunno, Massimiliano Esposito, Pasquale Viola, Davide Pisani, Giovambattista De Sarro, Milena Raffi, Alessandro Piras, Giuseppe Chiarella & Luca Gallelli. (2021) Drug–Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications. International Journal of Environmental Research and Public Health 18:24, pages 12936.
Crossref
Crossref
Umberto Maggiore, Alessandra Palmisano, Sebastiano Buti, Giulia Claire Giudice, Dario Cattaneo, Nicola Giuliani, Enrico Fiaccadori, Ilaria Gandolfini & Paolo Cravedi. (2021) Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?. Transplant International 34:12, pages 2442-2458.
Crossref
Crossref
Hefziba GreenRuth RahamimovGalia SpectreBenaya Rozen-ZviShmuel Fuchs, Shiri AvniRan Nissan. (2021) Apixaban Level and Its Influence on Immunosuppression and Graft Outcome in Kidney Transplant Recipients With Atrial Fibrillation. Therapeutic Drug Monitoring 43:5, pages 637-644.
Crossref
Crossref
Emilie Henin, Mirco Govoni, Massimo Cella, Christian Laveille & Giovanni Piotti. (2021) Therapeutic Drug Monitoring Strategies for Envarsus in De Novo Kidney Transplant Patients Using Population Modelling and Simulations. Advances in Therapy 38:10, pages 5317-5332.
Crossref
Crossref
Ming-Tso Yan, Chia-Ter Chao & Shih-Hua Lin. (2021) Chronic Kidney Disease: Strategies to Retard Progression. International Journal of Molecular Sciences 22:18, pages 10084.
Crossref
Crossref
Andrea Huppertz, Johanna Bollmann, Rouven Behnisch, Thomas Bruckner, Markus Zorn, Jürgen Burhenne, Walter E. Haefeli & David Czock. (2021) Differential Effect of a Continental Breakfast on Tacrolimus Formulations With Different Release Characteristics. Clinical Pharmacology in Drug Development 10:8, pages 899-907.
Crossref
Crossref
Dina Chen, Huijie Lu, Weiguo Sui, Liqing Li, Jian Xu, Tengfei Yang, Siyao Yang, Ping Zheng, Yan Chen, Jiejing Chen, Wen Xue, Qingping Li, Que Zheng, Demei Ye, Wolfgang Sadee, Danxin Wang, Wanying Qian, Liusheng Lai, Chuanjiang Li & Liang Li. (2021) Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients. The Pharmacogenomics Journal 21:3, pages 376-389.
Crossref
Crossref
Aline Milane, Georges Khazen, Layal Olaywan, Fatima Zarzour, Razan Mohty, Aline Sarkis, Pierre Zalloua & Antoine Barbari. (2021) Frequency of ABCB1 C3435T and CYP3A5*3 Genetic Polymorphisms in the Lebanese Population. Experimental and Clinical Transplantation 19:5, pages 434-438.
Crossref
Crossref
John M. LeClaire, Nathan J. Smith, Sonal Chandratre, Lisa Rein, Mohammed A. Kamalia, Takushi Kohmoto, Lyle D. Joyce & David L. Joyce. (2021) Solid organ donor–recipient race‐matching: analysis of the United Network for Organ Sharing database. Transplant International 34:4, pages 640-647.
Crossref
Crossref
Chia-Lin Shen, Bo-Sheng Wu, Tse-Jen Lien, An-Hang Yang & Chih-Yu Yang. (2021) BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection. Viruses 13:3, pages 487.
Crossref
Crossref
Barbara Infante, Nicola Coviello, Dario Troise, Matteo Gravina, Valeria Bux, Giuseppe Castellano & Giovanni Stallone. (2021) Rapamycin Inhibitors for Eye Squamous Cell Carcinoma after Renal Transplantation: A Case Report. Kidney and Blood Pressure Research 46:1, pages 121-125.
Crossref
Crossref
Lauren Schumacher, Abbie D. Leino & Jeong M. Park. (2020) Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:1, pages 103-118.
Crossref
Crossref
Shuting Wang, Wanfang Li, Jianbo Yang, Zengyan Yang, Cuiping Yang & Hongtao Jin. (2020) Research Progress of Herbal Medicines on Drug Metabolizing Enzymes: Consideration Based on Toxicology. Current Drug Metabolism 21:12, pages 913-927.
Crossref
Crossref
Stefano Turolo, Alberto Edefonti, Luciana Ghio, Sara Testa, William Morello & Giovanni Montini. (2020) CYP and SXR gene polymorphisms influence in opposite ways acute rejection rate in pediatric patients with renal transplant. BMC Pediatrics 20:1.
Crossref
Crossref
Chenyang Zhang, Haoqing Shao, Dandan Li, Nenqun Xiao & Zhoujin Tan. (2020) Role of tryptophan-metabolizing microbiota in mice diarrhea caused by Folium sennae extracts. BMC Microbiology 20:1.
Crossref
Crossref
Abbie D. Leino & Manjunath P. Pai. (2020) Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clinical Pharmacokinetics 59:11, pages 1317-1334.
Crossref
Crossref
Claudia Sandoval-Yañez, Leslie Escobar & Cristián A. Amador. (2020) The Advantages of Polymeric Hydrogels in Calcineurin Inhibitor Delivery. Processes 8:11, pages 1331.
Crossref
Crossref
Xiaojun Cai, Huizhu Song, Zheng Jiao, Hang Yang, Min Zhu, Chengyu Wang, Dong Wei, Lingzhi Shi, Bo Wu & Jingyu Chen. (2020) Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients. European Journal of Pharmaceutical Sciences 152, pages 105448.
Crossref
Crossref
Rongrong Wang, Weili Wang, Kuifen Ma, Xin Duan, Fangfang Wang, Mingzhu Huang, Wei Zhang & Tingbo Liang. (2020) Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study. Frontiers in Pharmacology 11.
Crossref
Crossref
Daniel A. Brazeau, Kristopher Attwood, Calvin J. Meaney, Gregory E. Wilding, Joseph D. Consiglio, Shirley S. Chang, Aijaz Gundroo, Rocco C. Venuto, Louise Cooper & Kathleen M. Tornatore. (2020) Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients. Frontiers in Genetics 11.
Crossref
Crossref
Marta Crespo, Sofía Zárraga, Ángel Alonso, Isabel Beneyto, Carmen Díaz Corte, Ana M. Fernandez Rodriguez, Antonio Franco, Domingo Hernández, Francisco Manuel González-Roncero, Carlos Jiménez Martín, Luisa Jimeno, Luis-Ricardo Lauzurica Valdemoros, Santiago Llorente, Auxiliadora Mazuecos, Antonio Osuna, Javier Paúl Ramos, Alberto Rodríguez Benot, Juan Carlos Ruiz San Millán, Ana Sánchez Fructuoso, Josep-Vicent Torregrosa & Lluis Guirado. (2020) Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper. Transplantation 104:8S2, pages S1-S12.
Crossref
Crossref
Hoang Lan Le, Marith I. FranckeLouise M. Andrews, Brenda C. M. de Winter, Teun van GelderDennis A. Hesselink. (2020) Usage of Tacrolimus and Mycophenolic Acid During Conception, Pregnancy, and Lactation, and Its Implications for Therapeutic Drug Monitoring: A Systematic Critical Review. Therapeutic Drug Monitoring 42:4, pages 518-531.
Crossref
Crossref
Teun van Gelder, Soufian Meziyerh, Jesse J. Swen, Aiko P. J. de Vries & Dirk Jan A. R. Moes. (2020) The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients. Frontiers in Pharmacology 11.
Crossref
Crossref
O. E. Gichkun. (2020) Monitoring tacrolimus whole blood concentrations. Russian Journal of Transplantology and Artificial Organs 22:2, pages 165-170.
Crossref
Crossref
Anne M. Schijvens, Saskia N. de Wildt & Michiel F. Schreuder. (2019) Pharmacokinetics in children with chronic kidney disease. Pediatric Nephrology 35:7, pages 1153-1172.
Crossref
Crossref
John Rizk & Mandeep R. Mehra. (2020) Anticoagulation management strategies in heart transplantation. Progress in Cardiovascular Diseases 63:3, pages 210-218.
Crossref
Crossref
Ningfang Cai, Xiujin Zhang, Chao Zheng, Lijun Zhu, Minfeng Zhu, Zeneng Cheng & Xi Luo. (2019) A novel random forest integrative approach based on endogenous CYP3A4 phenotype for predicting tacrolimus concentrations and dosages in Chinese renal transplant patients. Journal of Clinical Pharmacy and Therapeutics 45:2, pages 318-323.
Crossref
Crossref
Hong-Li Guo, Jing Xu, Jie-Yu Sun, Ling Li, Hui-Lei Guo, Xia Jing, Ze-Yue Xu, Ya-Hui Hu, Ze-Jun Xu, Fang Sun, Xuan-Sheng Ding, Feng Chen & Fei Zhao. (2020) Tacrolimus treatment in childhood refractory nephrotic syndrome: A retrospective study on efficacy, therapeutic drug monitoring, and contributing factors to variable blood tacrolimus levels. International Immunopharmacology 81, pages 106290.
Crossref
Crossref
Jianyu Liu, Dexi Chen, Bo Yao, Ge Guan, Chao Liu, Xinmin Jin, Xin Wang, Peng Liu, Yandong Sun & Yunjin Zang. (2020) Effects of donor–recipient combinational CYP3A5 genotypes on tacrolimus dosing in Chinese DDLT adult recipients. International Immunopharmacology 80, pages 106188.
Crossref
Crossref
Xiaojun Cai, Ruidong Li, Changcheng Sheng, Yifeng Tao, Quanbao Zhang, Xiaofei Zhang, Juan Li, Conghuan Shen, Xiaoyan Qiu, Zhengxin Wang & Zheng Jiao. (2020) Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients. European Journal of Pharmaceutical Sciences 145, pages 105237.
Crossref
Crossref
Yassamine Bentata. (2019) Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity. Artificial Organs 44:2, pages 140-152.
Crossref
Crossref
Gabriel Chan, Roy Hajjar, Lucie Boutin, Pierre Y. Garneau, Vincent Pichette, Jean-Philippe Lafrance, Naoual Elftouh, Josée Michaud & Patrick du Souich. (2020) Prospective study of the changes in pharmacokinetics of immunosuppressive medications after laparoscopic sleeve gastrectomy. American Journal of Transplantation 20:2, pages 582-588.
Crossref
Crossref
Ping Gao, Xin-Lei Guan, Rui Huang, Xiao-Fang Shang-guan, Jiang-Wei Luan, Mao-Chang Liu, Hua Xu & Xiao-Wen Wang. (2019) Risk factors and clinical characteristics of tacrolimus-induced acute nephrotoxicity in children with nephrotic syndrome: a retrospective case-control study. European Journal of Clinical Pharmacology 76:2, pages 277-284.
Crossref
Crossref
Dirk R.J. Kuypers. (2019) Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome. Clinical Pharmacology & Therapeutics 107:2, pages 347-358.
Crossref
Crossref
Danying Li, Huaijun Zhu, Xuemei Luo & Weihong Ge. (2020) PXR haplotype clusters will affect the pharmacokinetics of ciclosporin in Chinese renal transplant recipients. Journal of Pharmacy and Pharmacology 72:2, pages 271-278.
Crossref
Crossref
TsabeihOsman Idress, Safaa Badi & BashirAlsiddig Yousef. (2020) Assessment of knowledge and practice of Sudanese renal transplant recipients about tacrolimus usage: A cross-sectional study. International Journal of Health and Allied Sciences 9:2, pages 136.
Crossref
Crossref
Claudio Ponticelli & Richard J. Glassock. (2019) Prevention of complications from use of conventional immunosuppressants: a critical review. Journal of Nephrology 32:6, pages 851-870.
Crossref
Crossref
Andrea Huppertz, Christian Ott, Thomas Bruckner, Kathrin I. Foerster, Jürgen Burhenne, Johanna Weiss, Markus Zorn, Walter E. Haefeli & David Czock. (2019)
Prolonged‐Release Tacrolimus Is Less Susceptible to Interaction With the Strong
CYP
3A Inhibitor Voriconazole in Healthy Volunteers
. Clinical Pharmacology & Therapeutics 106:6, pages 1290-1298.
Crossref
Crossref
Aurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, Claire Laforest, Audrey Lavenu, Hélène Danjou, Sylvie Radenne, Vincent Leroy, Pauline Houssel-Debry, Christophe Duvoux, Nassim Kamar, Victor De Ledinghen, Valérie Canva, Filomena Conti, François Durand, Louis D’Alteroche, Danielle Botta-Fridlund, Christophe Moreno, Carole Cagnot, Didier Samuel, Claire Fougerou-Leurent, Georges-Philippe Pageaux, Jean-Charles Duclos-Vallée, Anne-Marie Taburet & Audrey Coilly. (2019) Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort. European Journal of Clinical Pharmacology 75:11, pages 1555-1563.
Crossref
Crossref
Abbie D. Leino, Chie Emoto, Tsuyoshi Fukuda, Michael Privitera, Alexander A. Vinks & Rita R. Alloway. (2019) Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus. American Journal of Transplantation 19:10, pages 2944-2948.
Crossref
Crossref
Yin-Lun Chang, Haw-Chyuan Lee, Hao-Lun Luo, Yen-Ta Chen, Po-Hui Chiang & Yuan-Tso Cheng. (2019) Preventive Role of mTOR Inhibitor in Post–Kidney Transplant Urothelial Carcinoma. Transplantation Proceedings 51:8, pages 2731-2734.
Crossref
Crossref
Ruth Rahamimov, Hagit Tifti-Orbach, Boris Zingerman, Hefziba Green, Shira Schneider, Avry Chagnac, Eytan Mor, Benjamin D. Fox & Benaya Rozen-Zvi. (2019) Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation. European Journal of Clinical Pharmacology 75:7, pages 951-958.
Crossref
Crossref
Xin Tian, Yuanyuan Chang, Jingyao Wei, Ruijuan Liu, Li Wang, Ji Zhang & Xiaojian Zhang. (2019) Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats. Journal of Pharmacy and Pharmacology 71:5, pages 788-796.
Crossref
Crossref
Olivia Campagne, Donald E. Mager, Daniel Brazeau, Rocco C. Venuto & Kathleen M. Tornatore. (2019) The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients. British Journal of Clinical Pharmacology 85:3, pages 516-529.
Crossref
Crossref
Olivia Campagne, Donald E. Mager & Kathleen M. Tornatore. (2018) Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities?. The Journal of Clinical Pharmacology 59:3, pages 309-325.
Crossref
Crossref
Marilyn E. Levi, Brian T. Montague, Christian Thurstone, Deepali Kumar, Shirish S. Huprikar & Camille N. Kotton. (2019) Marijuana use in transplantation: A call for clarity. Clinical Transplantation 33:2.
Crossref
Crossref
José R. Maldonado. 2019. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Psychosocial Care of End-Stage Organ Disease and Transplant Patients
17
48
.
Thomas Vanhove, Hylke de Jonge, Henriëtte de Loor, Marlies Oorts, Jan de Hoon, Anton Pohanka, Pieter Annaert & Dirk R. J. Kuypers. (2018) Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers. Drug Metabolism and Disposition 46:11, pages 1507-1513.
Crossref
Crossref
Luke M. Delzer, Larry K. Golightly, Tyree H. Kiser, Scott W. Biggins, Victor J. Lewis & Ike I. Kim. (2018) Calcineurin Inhibitor and Nonsteroidal Anti‐inflammatory Drug Interaction: Implications of Changes in Renal Function Associated With Concurrent Use. The Journal of Clinical Pharmacology 58:11, pages 1443-1451.
Crossref
Crossref
Guigao Lin, Xiao Zhang, Kuo Zhang, Yanxi Han, Liming Tan & Jinming Li. (2018)
Evaluation of tacrolimus-related
CYP3A5
genotyping in China: Results from the First External Quality Assessment Exercise
. Journal of Clinical Laboratory Analysis 32:8, pages e22563.
Crossref
Crossref
Olivia Campagne, Donald E. Mager, Daniel Brazeau, Rocco C. Venuto & Kathleen M. Tornatore. (2018)
Tacrolimus Population Pharmacokinetics and Multiple
CYP3A5
Genotypes in Black and White Renal Transplant Recipients
. The Journal of Clinical Pharmacology 58:9, pages 1184-1195.
Crossref
Crossref
Yi‐Chou Hou, Yen‐Chen Chang, Hao‐Lun Luo, Kuo‐Cheng Lu & Po‐Huang Chiang. (2018) Effect of mechanistic target of rapamycin inhibitors on postrenal transplantation malignancy: A nationwide cohort study. Cancer Medicine 7:9, pages 4296-4307.
Crossref
Crossref
Kenta Iwasaki, Nana Kitahata, Takahisa Hiramitsu, Takayuki Yamamoto, Takayuki Noda, Manabu Okada, Shunji Narumi, Yoshihiko Watarai, Yuko Miwa, Kazuharu Uchida, Yutaka Matsuoka, Kosei Horimi & Takaaki Kobayashi. (2018) Increased CD40L+PD-1+ follicular helper T cells (Tfh) as a biomarker for predicting calcineurin inhibitor sensitivity against Tfh-mediated B-cell activation/antibody production after kidney transplantation. International Immunology 30:8, pages 345-355.
Crossref
Crossref
Rosaleen Boswell & Glen J. Pearson. (2018) A review of the use of direct oral anticoagulant use in orthotopic heart transplantation recipients. Transplantation Reviews 32:3, pages 151-156.
Crossref
Crossref
Jacqueline R. KulbeIndrapal N. SinghJuan A. WangJohn E. CebakEdward D. Hall. (2018) Continuous Infusion of Phenelzine, Cyclosporine A, or Their Combination: Evaluation of Mitochondrial Bioenergetics, Oxidative Damage, and Cytoskeletal Degradation following Severe Controlled Cortical Impact Traumatic Brain Injury in Rats. Journal of Neurotrauma 35:11, pages 1280-1293.
Crossref
Crossref
Xiao Zhang, Guigao Lin, Liming Tan & Jinming Li. (2018) Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations. Biomedicine & Pharmacotherapy 102, pages 107-114.
Crossref
Crossref
Loredana Colla, Davide Diena, Maura Rossetti, Ana Maria Manzione, Luca Marozio, Chiara Benedetto & Luigi Biancone. (2018) Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era. Journal of Nephrology 31:3, pages 361-383.
Crossref
Crossref
Mar Gomis-Pastor, Esther Rodriguez-Murphy, Anna Feliu, Gerardo Ontiveros, Francesc Garcia-Cuy�s, Albert Salazar, Eulalia Roig & Maria Antonia Mangues. (2018) Strategies for the follow-up of patients with chronic diseases and polypharmacy: development and implementation of a new health care approach based on mobile technology (DIPP-mHeart Study). (Preprint). JMIR Formative Research.
Crossref
Crossref
Divya Dheer, Jyoti, Prem N. Gupta & Ravi Shankar. (2018) Tacrolimus: An updated review on delivering strategies for multifarious diseases. European Journal of Pharmaceutical Sciences 114, pages 217-227.
Crossref
Crossref
Teresa Maria Antonini, Audrey Coilly, Emilie Rossignol, Claire Fougerou-Leurent, Jérôme Dumortier, Vincent Leroy, Aurélie Veislinger, Sylvie Radenne, Danielle Botta-Fridlund, François Durand, Pauline Houssel-Debry, Nassim Kamar, Valérie Canva, Philippe Perré, Victor De Ledinghen, Alexandra Rohel, Alpha Diallo, Anne-Marie Taburet, Didier Samuel, Georges-Philippe Pageaux & Jean-Charles Duclos-Vallée. (2018) Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation. Transplantation 102:1, pages 119-126.
Crossref
Crossref
Rahul Maheshwari, Piyoosh Sharma, Ankit Seth, Neha Taneja, Muktika Tekade & Rakesh K. Tekade. 2018. Dosage Form Design Considerations. Dosage Form Design Considerations
337
369
.
Simon Tremblay & Rita R. Alloway. (2017) Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. The AAPS Journal 19:5, pages 1332-1347.
Crossref
Crossref
Marion Lepelley, Sophie Logerot, Xavier Fonrose & Céline Villier. (2017) Interaction pharmacocinétique entre la forme mucoadhésive de miconazole et le tacrolimus : à propos de 3 observations cliniques chez des patients greffés. Therapies 72:4, pages 475-482.
Crossref
Crossref
Elisabet Størset, Kristine Hole, Karsten Midtvedt, Stein Bergan, Espen Molden & Anders Åsberg. (2017) The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation. British Journal of Clinical Pharmacology 83:7, pages 1457-1465.
Crossref
Crossref
Elisabet Størset, Kristine Hole, Karsten Midtvedt, Stein Bergan, Espen Molden & Anders Åsberg. (2017) Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance. British Journal of Clinical Pharmacology 83:6, pages 1350-1352.
Crossref
Crossref
Chi Chiu Mok. (2017) Calcineurin inhibitors in systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 31:3, pages 429-438.
Crossref
Crossref
D.R. Kuypers & T. Vanhove. (2017) Predictive Modeling of Tacrolimus Dose Requirements: “All That Is Gold Does Not Glitter”. American Journal of Transplantation 17:4, pages 1144-1145.
Crossref
Crossref
James M. Neuberger, Wolf O. Bechstein, Dirk R.J. Kuypers, Patrizia Burra, Franco Citterio, Sabina De Geest, Christophe Duvoux, Alan G. Jardine, Nassim Kamar, Bernhard K. Krämer, Herold J. Metselaar, Frederik Nevens, Jacques Pirenne, Manuel L. Rodríguez-Perálvarez, Didier Samuel, Stefan Schneeberger, Daniel Serón, Pavel Trunečka, Giuseppe Tisone & Teun van Gelder. (2017) Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients. Transplantation 101:4S, pages S1-S56.
Crossref
Crossref
Li Wang, Yan-Hong Zhen, Xiao-Ming Liu, Jing Cao, Yan-Ling Wang & Li-Jun Huo. (2017) Inhibition of calcineurin by FK506 stimulates germinal vesicle breakdown of mouse oocytes in hypoxanthine-supplemented medium. PeerJ 5, pages e3032.
Crossref
Crossref
. Experimental and Clinical Transplantation 15:1.
Crossref
Crossref
Ashwani K. Gupta & Nader Bahri. (2016) Isolated diplopia associated with calcineurin inhibitor therapy in a patient with idiopathic membranous nephropathy: a case report. BMC Nephrology 17:1.
Crossref
Crossref
Naomi Hauser, Tanmay Sahai, Rocco Richards & Todd Roberts. (2016) High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana. Case Reports in Transplantation 2016, pages 1-3.
Crossref
Crossref